Read + Share
Amedeo Smart
Independent Medical Education
Derigs P, Schubert ML, Dreger P, Schmitt A, et al. Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study. Leukemia 2024 Aug 27. doi: 10.1038/s41375-024-02392.PMID: 39192036
Email
LinkedIn
Privacy Policy